Evidence map›Paper›PMID 28592992›Full record

ArticleJournal of biological engineering2017

Streamlining recombination-mediated genetic engineering by validating three neutral integration sites in

Anne Ilse Maria Vogel, Rahmi Lale, Martin Frank Hohmann-Marriott

Abstract read
In one paragraph

Article in Journal of biological engineering, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Improving the Transformation Efficiency ofACS synthetic biology · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Insights into cyanobacterial alkane biosynthesis.Journal of industrial microbiology & biotechnology · 2022
    Review
  10. Review
  11. Heterologous production of cyanobacterial compounds.Journal of industrial microbiology & biotechnology · 2021
    Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anne Ilse Maria VogelDepartment of Biotechnology, PhotoSynLab, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
Rahmi LaleDepartment of Biotechnology, PhotoSynLab, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
Martin Frank Hohmann-MarriottDepartment of Biotechnology, PhotoSynLab, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

resultsWe designed three BioBrick-compatible genetic modules, each targeting a separate neutral integration site, A2842, A0935, and A0159, with varying length of homologous region, spanning from 100 to 800 nt. The performance of the different modules for achieving DNA integration were tested. Our results demonstrate that 100 nt homologous regions are sufficient for inserting a 1 kb DNA fragment into the

conclusionsThe optimized transformation protocol reported in this study provides an efficient way to perform genetic engineering in

Indexed as

BioBrickCyanobacteriaGenetic engineeringNeutral integration sitesSynechococcus sp. PCC7002Synthetic biologyTransformation

Identifiers

PMID28592992
PMCPMC5458483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.